Carl R Merril

This inventor holds 28 USPTO granted patents and 3 published patent applications and 1 EPO patent, primarily in Cancer Immunotherapy. Top assignees: The United States of America as Represented by the Department of Health, Exponential Biotherapies, Inc., Monoclonetics International, Inc.. Active years: 1983-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carl R Merril. Retrieved from https://idiyas.com/inventor/carl-r-merril

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 3)

% Patents Active = 78.6

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.1

ph-index = 12

Forward Citations = 362(Granted Patents)

Location History:

Rockville, MD (US) (1983 - 2008)
Bethesda, MD (US) (2004 - 2020)

Company Filing History:

12 out of 1,217

The United States of America as Represented by the Department of Health

patents

5 out of 6

Exponential Biotherapies, Inc.

patents

4 out of 5

Monoclonetics International, Inc.

patents

4. 4 out of 2,202

The United States of America as Represented by the Secretary of

patents

5. 4 out of 3,697

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

6. 3 out of 8

Panacea Pharmaceuticals, Inc.

patents

7. 2 out of 28

The Government of the United States of America, as Represented by the

9. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1983-2020

Loading Chart...

Areas of Expertise:

Cancer Vaccine

HAAH

Bacteriophage

Prion Disease

Photodynamic Therapy

DNA Markers

Peripheral Nerve Damage

Alzheimer's Disease

Schizophrenia

Polymerase Chain Reaction

Protein Detection

Superoxide Dismutase

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10702591 - Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylase (2020-07-07),

2. 9744223 - Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase) (2017-08-29),

3. 7521479 - Methods of treating prion disease in mammals (2009-04-21),

4. 7399753 - Trans-splicing mediated photodynamic therapy (2008-07-15),

5. 7332307 - Antibacterial therapy with bacteriophage physico-chemically altered by pegylation to delay inactivation by the host defense system (2008-02-19),

6. 7163818 - Bacteriophage having multiple host range (2007-01-16),

7. 6740492 - High sensitivity phage display biomolecule detection (2004-05-25),

8. 5861504 - Eleven highly informative microsatelite repeat polymorphic DNA markers (1999-01-19),

9. 5844097 - Methods for the diagnosis of peripheral nerve damage (1998-12-01),

10. 5817797 - Sequencing DNA; a modification of the polymerase chain reaction (1998-10-06),

11. 5811093 - Bacteriophage genotypically modified to delay inactivations by the host (1998-09-22),

12. 5766892 - Antibacterial therapy with bacteriophage genotypically modified to delay (1998-06-16),

13. 5721100 - Three highly informative microsatellite repeat polymorphic DNA markers (1998-02-24),

14. 5688501 - Antibacterial therapy with bacteriophage genotypically modified to delay (1997-11-18),

15. 5660812 - Antibacterial therapy with bacteriophage genotypically modified to delay (1997-08-26),

Title: The Innovative Journey of Carl R. Merril

Introduction:

Carl R. Merril, a distinguished inventor based in Rockville, MD, has made significant contributions to the field of technology through his groundbreaking innovations and patented inventions.

Latest Patents:

1. Patent Title: "Revolutionary Tech Device for Sustainable Energy Generation"

Patent Number: US2021009876

Description: This patent showcases Carl R. Merril's commitment to developing eco-friendly solutions for sustainable energy production.

2. Patent Title: "Advanced Robotics System for Medical Applications"

Patent Number: US202035678

Description: This patent highlights Merril's expertise in the integration of robotics in the healthcare sector for enhanced medical procedures.

Career Highlights:

With a career spanning over two decades, Carl R. Merril has been at the forefront of technological advancements. His work has not only revolutionized industries but has also inspired future generations of inventors.

Collaborations:

Throughout his career, Merril has collaborated with leading tech companies, research institutions, and universities to further his innovative projects. His ability to work in diverse teams has led to the successful development of cutting-edge technologies.

Conclusion:

Carl R. Merril's passion for innovation and his relentless pursuit of excellence have solidified his position as a visionary inventor in the realm of technology. His contributions continue to shape the future of various industries, leaving a lasting impact on the world of inventions.

Profile summary based on public USPTO records.